PEQSX
Price
$34.91
Change
+$0.26 (+0.75%)
Updated
Dec 24 closing price
VVIAX
Price
$66.83
Change
+$0.56 (+0.85%)
Updated
Dec 24 closing price
Ad is loading...

PEQSX vs VVIAX

Header iconPEQSX vs VVIAX Comparison
Open Charts PEQSX vs VVIAXBanner chart's image
Putnam Large Cap Value R6
Price$34.91
Change+$0.26 (+0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$66.83
Change+$0.56 (+0.85%)
VolumeN/A
CapitalizationN/A
PEQSX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEQSX vs. VVIAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQSX is a Buy and VVIAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 195B vs. PEQSX (33.7B). VVIAX pays higher dividends than PEQSX: VVIAX (2.36) vs PEQSX (1.52). PEQSX was incepted earlier than VVIAX: PEQSX (12 years) vs VVIAX (24 years). PEQSX is a more actively managed with annual turnover of: 12.00 vs. VVIAX (10.00). PEQSX has a lower initial minimum investment than VVIAX: PEQSX (0) vs VVIAX (3000). PEQSX (15.54) and VVIAX (15.46) have marching annual gain over last year. VVIAX (42.96) and PEQSX (42.71) have equivalent 5 years return.
PEQSXVVIAXPEQSX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD14.71214.743100%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.7B195B17%
Annual Yield % from dividends1.522.3664%
Returns for 1 year15.5415.46101%
Returns for 3 years19.0718.30104%
Returns for 5 years42.7142.9699%
Returns for 10 years85.90100.5385%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTST4.230.20
+4.96%
Data Storage Corp
REVG31.510.68
+2.21%
REV Group
AQN4.490.01
+0.22%
Algonquin Power & Utilities Corp
BIIB149.02-0.36
-0.24%
Biogen
FDMT5.81-0.07
-1.19%
4D Molecular Therapeutics